These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 1200663

  • 1. Long-term intramuscular administration of triamcinolone acetonide. Effect on the hypothalamic-pituitary-adrenal axis.
    Carson TE, Daane TA, Weinstein RL.
    Arch Dermatol; 1975 Dec; 111(12):1585-7. PubMed ID: 1200663
    [Abstract] [Full Text] [Related]

  • 2. Long-term intramuscular administration of triamcinolone acetonide.
    Mikhail GR, Sweet LC, Mellinger RC.
    Arch Dermatol; 1977 Jan; 113(1):111. PubMed ID: 831617
    [No Abstract] [Full Text] [Related]

  • 3. Parenteral long-acting corticosteroids: effect on hypothalamic-pituitary-adrenal function.
    Mikhail GR, Sweet LC, Mellinger RC.
    Ann Allergy; 1973 Jul; 31(7):337-43. PubMed ID: 4352151
    [No Abstract] [Full Text] [Related]

  • 4. Pituitary-adrenal function following topical triamcinolone acetonide and occlusion.
    Taylor KS, Malkinson FD, Gak C.
    Arch Dermatol; 1965 Aug; 92(2):174-7. PubMed ID: 11850923
    [Abstract] [Full Text] [Related]

  • 5. Effect of long-acting parenteral corticosteroids on adrenal function.
    Mikhail GR, Livingood CS, Mellinger RC, Paige TN, Salyer HL.
    Arch Dermatol; 1969 Sep; 100(3):263-8. PubMed ID: 4241801
    [No Abstract] [Full Text] [Related]

  • 6. Hypothalamic-pituitary-adrenal axis following glucocorticoid prophylaxis against acute mountain sickness.
    Basu M, Sawhney RC, Kumar S, Pal K, Prasad R, Selvamurthy W.
    Horm Metab Res; 2002 Jun; 34(6):318-24. PubMed ID: 12173072
    [Abstract] [Full Text] [Related]

  • 7. [Suppression of pituitary-adrenal axis by triamcinolone acetonide in asthmatics].
    Li XH, Zhong NS.
    Zhonghua Nei Ke Za Zhi; 1991 Sep; 30(9):542-5, 593. PubMed ID: 1666866
    [Abstract] [Full Text] [Related]

  • 8. [Secondary adrenal insufficiency after local injections of triamcinolone acetonide].
    Schott S, Schnauder G, Müssig K.
    Dtsch Med Wochenschr; 2009 Feb; 134(7):298-301. PubMed ID: 19197811
    [Abstract] [Full Text] [Related]

  • 9. Triamcinolone in corticosteroid-resistant asthma.
    Peake MD, Cayton RM, Howard P.
    Br J Dis Chest; 1979 Jan; 73(1):39-44. PubMed ID: 435372
    [Abstract] [Full Text] [Related]

  • 10. Effects of cloprednol and other corticosteroids on hypothalamic-pituitary-adrenal axis function.
    Ortega E, Rodriguez C, Strand LJ, Segre E.
    J Int Med Res; 1976 Jan; 4(5):326-37. PubMed ID: 1028634
    [Abstract] [Full Text] [Related]

  • 11. Prospective use of intramuscular triamcinolone acetonide in pseudogout.
    Roane DW, Harris MD, Carpenter MT, Finger DR, Jarek MJ, Alloway JA, Erickson AR, Venanzi WE, Drehmer TJ.
    J Rheumatol; 1997 Jun; 24(6):1168-70. PubMed ID: 9195527
    [Abstract] [Full Text] [Related]

  • 12. Tests of hypothalamic-pituitary-adrenal function in man.
    Jacobs HS, Nabarro JD.
    Q J Med; 1969 Oct; 38(152):475-91. PubMed ID: 5355539
    [No Abstract] [Full Text] [Related]

  • 13. A prospective observational study evaluating hypothalamic-pituitary-adrenal axis alteration and efficacy of intramuscular triamcinolone acetonide for steroid-responsive dermatologic disease.
    Reddy S, Ananthakrishnan S, Garg A.
    J Am Acad Dermatol; 2013 Aug; 69(2):226-31. PubMed ID: 23545370
    [Abstract] [Full Text] [Related]

  • 14. [The pilot study of intravitreal injection of triamcinolone acetonide for treatment of retinal detachment with choroidal detachment].
    Duan AL, Wang JZ, Wang NL.
    Zhonghua Yan Ke Za Zhi; 2005 Jul; 41(7):606-9. PubMed ID: 16080894
    [Abstract] [Full Text] [Related]

  • 15. The treatment of skin disorders with intramuscular triamcinolone acetonide.
    Rosten M.
    N Z Med J; 1970 Oct; 72(461):253-5. PubMed ID: 5275018
    [No Abstract] [Full Text] [Related]

  • 16. Micropulsed laser photocoagulation and intravitreal triamcinolone acetonide injection for the treatment of retinal angiomatous proliferation.
    Roth DB, Scott IU, Gloth JM, Green SN, Yarian DL, Wheatley M.
    Retina; 2007 Oct; 27(9):1201-4. PubMed ID: 18046225
    [Abstract] [Full Text] [Related]

  • 17. Comparison of triamcinolone acetonide with indomethacin in the treatment of acute gouty arthritis.
    Alloway JA, Moriarty MJ, Hoogland YT, Nashel DJ.
    J Rheumatol; 1993 Jan; 20(1):111-3. PubMed ID: 8441139
    [Abstract] [Full Text] [Related]

  • 18. Treatment of psoriasis with triamcinolone acetonide 0.1% under occlusion: a comparison of two hydrocolloid dressings.
    González JR, Cabán F.
    Bol Asoc Med P R; 1990 Jul; 82(7):288-91. PubMed ID: 2261015
    [Abstract] [Full Text] [Related]

  • 19. Comparison of the hypothalamic-pituitary-adrenal axis susceptibility upon single-dose i.m. depot versus long-acting i.v. triamcinolone acetonide therapy: a direct pharmacokinetic correlation.
    Abraham G, Demiraj F, Ungemach FR.
    J Endocrinol; 2006 Nov; 191(2):491-6. PubMed ID: 17088419
    [Abstract] [Full Text] [Related]

  • 20. Intravitreal triamcinolone acetonide for treatment of cystoid macular oedema in patients with retinitis pigmentosa.
    Ozdemir H, Karacorlu M, Karacorlu S.
    Acta Ophthalmol Scand; 2005 Apr; 83(2):248-51. PubMed ID: 15799743
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.